Longeveron Inc. Common Stock
Symbol: LGVN (NASDAQ)
0.74
▼ (-1.62%) -0.012
Company Description:
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Key Stats
- Today's Open: $0.78
- Today's High: $0.795
- Today's Low: $0.741
- Today's Volume: 688.02K
- Yesterday Close: $0.7552
- Yesterday High: $0.86
- Yesterday Low: $0.74
- Yesterday Volume: 1.97M
- Last Min Volume: 220
- Last Min High: $0.743
- Last Min Low: $0.743
- Last Min VWAP: $0.743
Company Profile
- Name: Longeveron Inc. Common Stock
- Website: https://www.longeveron.com
- Listed Date: 2021-02-12
- Location: MIAMI, FL
- Market Status: Active
- CIK Number: 0001721484
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $11.46M
- Round Lot: 100
- Outstanding Shares: 15.18M
- Asset Type: CS
RECENT FILINGS FOR LGVN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-15 | SCHEDULE 13G | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-11 | 424B4 | View |
| 2025-08-08 | EFFECT | View |
| 2025-08-08 | S-1/A | View |
| 2025-08-04 | S-1 | View |
| 2025-07-21 | DRS | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 4 | View |
Latest News on LGVN